Drug induced very severe hypertriglyceridemia in a pediatric stem cell transplant recipient

Pediatr Blood Cancer. 2022 Feb;69(2):e29379. doi: 10.1002/pbc.29379. Epub 2021 Oct 4.

Authors

Jennifer Schweiger^{1

2}, Kynlon Phillips¹, Arpita Patel³, Carmen Echols^{1

2}

Affiliations

¹ Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA.
² University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
³ Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA.

PMID: 34608751
DOI: 10.1002/pbc.29379

No abstract available

Publication types

Letter

MeSH terms

Child
Humans
Hyperlipidemias*
Hypertriglyceridemia* / chemically induced
Stem Cell Transplantation / adverse effects